Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

BDCs Oversold on Exaggerated Concerns: Buy for High Yields

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day 10/20/2025

Global Analyst Adrian Day looks at the sharp decline in the stock prices of Business Development Companies, as well developments at his companies, including preliminary 3Q results from many gold companies.

Ares Capital Corp. (ARCC:NASDAQ) and Gladstone Investment Corp. (GAIN: NASDAQ) have both fallen sharply in the last six weeks, along with the entire BDC sector.

The Vaneck ETF is down 16%, to a 52-week low.

There are three main concerns.

First, when the Federal Reserve cut its key rate in mid-September, this meant that BDC returns would be reduced, given that the overwhelming majority of BDC loans are set on floating rates.

Second, there is concern about how the small businesses to which BDCs lend will hold up in a weakening economy.

And third, and arguably most worrying, are concerns about private credit, following a couple of spectacular credit failures in a market that has experienced tremendous growth in recent years.

Lower interest rates will, on balance, reduce income, other things being equal, but we should remember that many BDCs have floating rate debt as well, so what they lose on one side of the ledger they gain on the other. In addition, lower rates are likely on balance to help companies in their portfolios.

Private Credit Is a Concern, but BDCs Are Not the Problem

Although we are concerned about the private credit market, and also believe some BDCs may be forced to reduce their distributions in a coming slowdown, the better BDCs are in a solid position.

As we have written before, companies like the two on our list each use independent sources to value their loans, removing the major risk of private equity that marks are too favorable. This does not mean that there cannot be problems at the companies to which they have made loans, but it helps ensure that the valuations are realistic.

They are more solid than the private equity funds now being pitched to smaller investors. We have written about both recently, Ares and Gladstone. Ares, the largest BDC, trading at a small discount to NAV, is yielding just over 10%, while the smaller Gladstone, trading just north of NAV, yields over 7% from its regular monthly distributions, but over 11% when the last extra distribution (from capital gains) is included.

Both Ares and Gladstone are Buys now.

Barrick Sells Another Mine

Barrick Mining Corp. (ABX:TSX; B:NYSE) sold its majority stake in the Tongon gold mine in Côte d’Ivoire to a private group for up to $305 million, a third of it in contingent payments tied to the gold price and resource conversion milestones, and $23 million a loan repayment.

The sale was in the works before the change in management, and follows the sale of Hemlo in Toronto, part of an asset streamlining process.

The price received is certainly meaningfully less than was anticipated, but adding cash to the balance sheet while divesting of non-core assets is a positive.

Hold.

Or and Triple Flag Report Initial Results, Both on Track for Year

OR Royalties (OR:TSX; OR:NYSE) reported operating results a little shy of consensus estimates, but record revenue due to the high gold price.

The company ended the quarter with $57 million in cash and no debt after paying back $35 million during the quarter.

The company is tracking for its full-year guidance, though towards lower end of range. It had however stated that the second-half of the year would be stronger than the first, so may well catch up towards its mid-point of guidance.

Hold.

Triple Flag Precious Metals Corp. (TFPM:TSX; TFPM:NYSE) reported preliminary third-quarter results above estimates, driven by record performance at the cornerstone Northparkes stream.

Two new stream also produced their first GEOs for the company, which is tracking well for its full-year production guidance.

Hold.

Fortuna Advances Next Mine, as Production Mixed

Fortuna Mining Corp. (FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE) has filed an Environmental and Social Impact Assessment for its Diamba Sud project in Senegal, a key step towards eventual. Development of the mine. A PEA is planned for before year end, with a production decision in the first half of next year. The company also announced production numbers, with Séguéla, its largest mine, once again exceeding estimates, while Lindero underperformed.

Although production was down modestly on the year-ago quarter (72K GEO vs 73K in 2024), Fortuna has sold two small and declining mines, and the production is in line with restated guidance allowing for the mine sales.

Although Fortuna’s stock price is well up this year — over 100%, matching the appreciation in the GDX — it remains relatively good value, trading at a cash flow multiple under 6.

If you are new to the sector and building a portfolio, it can be bought here.

Altius’ PG Portfolio Gains

Altius Minerals Corp. (ALS:TSX) said its junior equities portfolio, part of its project generation business, was valued at $44 million at quarter end, after receiving $68 million during the quarter from the Orogen transaction.

The portfolio was $87 million at the end of the second quarter, so including receipts, is well up. Altius is a core holding for broad exposure to the commodities complex, top, insightful management, a good balance sheet, and strong pipeline of potential new revenue sources.

If you do not own, it can be purchased here.

Orogen’s Exploration Properties Show Promise

Orogen Royalties Inc. (OGN:TSXV; OGNNF:OTC) conducted another exploration property webinar. Though somewhat technical and aimed primarily at potential partners, there was interesting background for the investor, particularly CEO Paddy Nichol’s introduction.

Vice president of Exploration Laurence Pryer discussed Table Mountain which he called “the best opportunity . . . one I didn’t think still existed in Nevada.”

How is that for a teaser?

Orogen has four alliances, with Altius, triple Flag, South 32, and BHP, as well as seven projects under options, and several which it has sold for a royalty. Orogen is one of my favorite junior companies; we already have on our list from our position acquired before the transaction and spin-out with Triple Flag.

I would like to see a pullback to buy more.

TOP BUYS this week, in addition to above include Lara Exploration Ltd. (LRA:TSX.V) and Fox River Resources Corp. (FOX:CSE).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Barrick Mng Corp., Triple Flag Precious Metals, Or Royalties Inc., Fortuna Mining Corp., Altius Minerals Corp., Orogen Royalties Inc., Lara Exploration Ltd. and Fox River Resources Corp.
  2. Adrian Day: I, or members of my immediate household or family, own securities of: All. My company has a financial relationship with: None. My company has purchased stocks mentioned in this article for my management clients: All. I determined which companies would be included in this article based on my research and understanding of the sector.
  3. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Adrian Day Disclosures

Adrian Day’s Global Analyst is distributed for $990 per year by Investment Consultants International, Ltd., P.O. Box 6644, Annapolis, MD 21401. (410) 224-8885. www.AdrianDayGlobalAnalyst.com. Publisher: Adrian Day. Owner: Investment Consultants International, Ltd. Staff may have positions in securities discussed herein. Adrian Day is also President of Global Strategic Management (GSM), a registered investment advisor, and a separate company from this service. In his capacity as GSM president, Adrian Day may be buying or selling for clients securities recommended herein concurrently, before or after recommendations herein, and may be acting for clients in a manner contrary to recommendations herein. This is not a solicitation for GSM. Views herein are the editor’s opinion and not fact. All information is believed to be correct, but its accuracy cannot be guaranteed. The owner and editor are not responsible for errors and omissions. © 2023. Adrian Day’s Global Analyst. Information and advice herein are intended purely for the subscriber’s own account. Under no circumstances may any part of a Global Analyst e-mail be copied or distributed without prior written permission of the editor. Given the nature of this service, we will pursue any violations aggressively.

( Companies Mentioned: ALS:TSX, ARCC:NASDAQ, ABX:TSX; B:NYSE, FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE, GAIN: NASDAQ, OR:TSX; OR:NYSE, OGN:TSXV;OGNNF:OTC, TFPM:TSX;TFPM:NYSE, )


Source: https://www.streetwisereports.com/article/2025/10/20/bdcs-oversold-on-exaggerated-concerns-buy-for-high-yields.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login